NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Isolation Methods of Peripheral Blood Mononuclear Cells in Spanish Biobanks: An Overview.

Author(s): Consuegra I, Rodríguez-Aierbe C, Santiuste I, Bosch A, Martínez-Marín R, Fortuto MA, Díaz T, Martí S, Muñoz-Fernández MÁ

Publication: Biopreserv Biobank, 2017, Vol. 15(4), Page 305-309

PubMed ID: 28398808 PubMed Review Paper? No

Purpose of Paper

This paper compared the effects of blood collection tube type and cryopreservation media used on the viability of white cells from peripheral blood from healthy volunteers and diseased patients processed at seven different biobanks.

Conclusion of Paper

White cell viability was not significantly different between specimens collected in Vacutainer tubes and LeucoSep tubes. However, it was highest in adults at biobanks that used cryopreservation media containing 90% FCS + 10% DMSO rather than 92.5% FCS + 7.5% DMSO or 50% RPMI + 40% FCS + 10% DMS0. White cell viability was also significantly higher in blood from healthy adults than those with inflammatory, metabolic, infectious, or rare diseases.

Studies

  1. Study Purpose

    This study compared the effects of blood collection tube type and cryopreservation media used on the viability of white cells from peripheral blood processed at seven biobanks of the Spanish Hematic Derivatives Group. Peripheral blood was collected in Vacutainer or LeucoSep tubes by an unspecified method from healthy adult volunteers and patients (adult and pediatric) with inflammatory, metabolic, infectious, and rare diseases. After collection, the biobanks maintained the tubes at room temperature and within 4 h white cells were isolated by density gradient centrifugation.  Following isolation, specimens were cryopreserved with 90% FCS + 10% DMSO at four of seven biobanks, 92.5% FCS + 7.5% DMSO at one biobank, and 50% RPMI + 40% FCS + 10% DMS0 at the remaining two biobanks. White cells were stored in vapor-phase LN for a mean time of 14 months before viability was determined by manual counting on a light microscope or using an automated cell counter.

    Summary of Findings:

    White cell viability was not significantly different between specimens collected in Vacutainer tubes and LeucoSep tubes (74% and 75.5%, respectively, P=0.4768). Post-thaw white cell viabilities for the four biobanks using 90% FCS + 10% DMSO as cryopreservation media were 77%–86% in adult patients. Significantly lower white cell viabilities of 62% and 65%, were found at the two biobanks using 50% RPMI + 40% FCS + 10% DMS0 (P<0.0001). Although slightly lower viability for specimens from adult patients was noted at the biobank that used 92.5% FCS + 7.5% DMSO (74%), viability of white cells from pediatric specimens at that biobank using the same media was higher (84%). The authors conclude that the slightly lower viability in adult patients was not attributable to reducing the percentage DMSO from 10% to 7.5%. White cell viability was significantly higher in healthy adults than those with inflammatory, metabolic, infectious, or rare diseases (P=0.0022).

    Biospecimens
    Preservative Types
    • Frozen
    • Other Preservative
    Diagnoses:
    • Other diagnoses
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Fluorescent microscopy
    Cell count/volume Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Concentration of fixative 90% FCS + 10% DMSO
    92.5% FCS + 7.5% DMSO
    50% RPMI + 40% FCS + 10% DMS0
    Biospecimen Acquisition Type of collection container/solution BD Vacutainer tube
    LeucoSep tube
    Preaquisition Patient age Adult
    Pediatric
    Preaquisition Diagnosis/ patient condition Normal
    Patients with inflammatory, metabolic, infectious, or rare diseases
    Storage Short-term storage solution 90% FCS + 10% DMSO
    92.5% FCS + 7.5% DMSO
    50% RPMI + 40% FCS + 10% DMS0

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...